Got News to Share? Send 2 FREE Releases ↓
All News Topics | Events By Topic | By Country | By State | By Date

CNS Orphan Diseases - The Alternative Route in CNS

Submit News
Date: 10-Mar-15 to 10-Mar-15
Location: Holiday Inn Bloomsbury / London / United Kingdom
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

The challenges of drug development in CNS is well known, the recent failures of the large phase III trials in Alzheimer's disease illustrates the problem. There is however an alternative route in CNS which can prove to be more accessible to small and medium sized companies, and that is CNS Orphan diseases. Diseases such as Huntington’s disease (HD), Amyotrophic lateral scerlosis (ALS), Progressive supranuclear palsy (PSP) or Fronto Temporal Dementia (FTD) can be initial substitutes for the likes of Alzheimer's disease or Parkinson's disease in which to test the effectiveness of a drug.

This masterclass will look at the challenges and potential advantages of developing drugs in CNS Orphan diseases, compared to larger CNS indications and also looks at the support that is available to drug developers in orphan diseases. It will look at case studies of drug companies who have followed this route.

Why you should attend:

• Discover alternative routes for drug development in CNS disorders
• Minimise the risks associated with developing drugs in larger CNS conditions
• Learn from past trials and from the successes small-medium sized pharma and biotechs have had in developing drugs in orphan CNS indications
• Evaluate the support structures available to those undertaking clinical trials in orphan disease indications
• Identify the challenges involved in developing compounds in Orphan CNS disease indications

Hosted by: Susan McGoldrick, Consultant, The CNS Company

HOW TO REGISTER
Book before 30th January & save £100
Register online at www.smi-online.co.uk/2015cns-orphan-diseases1.asp
Contact Kinga Gradalska on +44 (0) 20 7827 6192 or email kgradalska@smi-online.co.uk

Exhibitors

Susan McGoldrick, Consultant, The CNS Company

Go to event website